Cellaviv Retools and Relaunches Website

Making Cellaviv a more Customer Friendly and Customer Focused Brand

Feb 01, 2016, 16:36 ET from Emergent Health Corp.

BOCA RATON, Fla., Feb. 1, 2016 /PRNewswire/ -- Cellaviv, a wholly owned subdivision of Emergent Health Corp. (OTC PINK: EMGE), is launching a refreshed website and modifying its distribution channel today.  Cellaviv, formed in 2006, has roots in its formation going back to 2000, by founder, Dr. John Cappello, who was stricken with Parkinson Disease. His symptoms forced him to retire from the active practice of medicine. This facilitated a search that led him in 2005 to uncover scientific data regarding the ability of certain botanicals to increase adult stem cells in the body's circulation. Through his personal experience, Dr. Cappello developed a line of patented and patent pending nutraceuticals that contain the science of stem cell nutrition. The products include Multi-vitamins and Stem Cell supplements, an Anti-Aging line, Weight Management line, Male Wellness, Joint and Cardio support.  Cellaviv was originally made available through a direct sales channel, establishing a large number of loyal customers whose support was also compensated for referrals. Today Cellaviv is launching a fully remodeled and refreshed retail, e-Commerce website.  Cellaviv existing customers will be offered additional discounts to continue their monthly health nutrition needs and new customers will receive discounts during the initial launch period. This refresh will simplify the customer shopping experience.


Forward Looking Statement
The statements contained herein may include statements of future expectations and other forward-looking statements that are based on management's current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements.

Contact: Ann Vandersteel
Phone 561.961.4344
Fax 561.961.4572


SOURCE Emergent Health Corp.